General MedicationsORALStandard
KERENDIA
FINERENONE
Standard Dose
20MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Prescription
Summary
Approval overview KERENDIA is listed in Drugs@FDA under application 215341 (NDA).
Review priority: PRIORITY Marketing status: Prescription Active ingredient FINERENONE Form and strength TABLET;ORAL - 20MG Sponsor BAYER HLTHCARE Submission history Latest submission status date: 2025-07-11 00:00:00.
Structured Monograph
Clinical summary
Approval overview KERENDIA is listed in Drugs@FDA under application 215341 (NDA). Review priority: PRIORITY Marketing status: Prescription Active ingredient FINERENONE Form and strength TABLET;ORAL - 20MG Sponsor BAYER HLTHCARE Submission history Latest submission status date: 2025-07-11 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.